Reverse Phase - High Performance Liquid Chromatography Method for the Analysis of Paracetamol

 

Abhishek K Jain*, C. P. Jain and Anshu Sharma

University Dept. of Pharmaceutical Sciences, M.L.S. University, Udaipur, Rajasthan

*Corresponding Author E-mail:  abhi181281@yahoo.com

ABSTRACT

An accurate, simple, reproducible and sensitive method for the determination of paracetamol was developed and validated. Paracetamol was identified using a , Microsorb-MV 100-5 C18 column (250 x 4.6 mm; North America) by binary gradient elution with a flow rate of 0.5 ml/min. The mobile phase composition was methanol: water (30:70) (v/v) and spectrophotometric detection was carried out at 245 nm. The linear range of determination for paracetamol was 0.816-250 μg/ml. The method was shown to be linear, reproducible, specific and sensitive.

 

KEYWORDS: Paracetamol, Reverse phase-High performance liquid chromatography, Validation.

 


INTRODUCTION:

Paracetamol (acetaminophen) is one of the most popular over-the-counter analgesic and antipyretic drugs. Paracetamol is available in different dosage forms; such as tablet, capsules, drops, elixirs, suspensions and suppositories etc. Dosage forms of paracetamol and its combinations with other drugs have been listed in various pharmacopoeias 1,2. The combination of paracetamol with dipyrone is used as an antipyretic, analgesic and anti-inflammatory drug. Numerous methods have been reported for the analysis of paracetamol alone and its combinations with other drugs in pharmaceuticals or in biological fluids. Paracetamol has been determined in combination with other drugs using titrimetry 3,4, voltammetry5, fluorimetry6, colorimetry6, UV-spectrophotometry7, high-performance liquid chromatography (HPLC)8. The determination of paracetamol in tablets by spectrophotometry was reported in the literature. A suitable HPLC method to determine paracetamol with simple composition of mobile phase was not located in the literature survey. The objective of this study was to develop and validate a specific, accurate, precise and reproducible quality control method for paracetamol with effective simple composition of mobile phase.

 

MATERIAL AND METHODS:

Chemicals:

Paracetamol (acetaminophen) was used from USP reference standard received from S. D. Fine-Chem Limited, Mumbai, M.H., India. Chromatographic grade double-distilled water, HPLC-grade methanol (Riedel-de Haen-34860 were used.

 

Apparatus:

The method development was performed with a HPLC-LC type system consisting of a dual plunger, pulse compensating operation solvent delivery system; isocratic, constant pressure, gradient and external input solvent delivery mode (make Younglin Instrument, Korea; Model no. Acme 9000 HPLC). Dual wavelength UV/Vis absorbance detector; wavelength range 190-900nm and Basic Marathan type 816 version 1.4, march 1994 autosampler using a 20 μl sample loop with SP 930 D gradient pump. The detector was set at 245 nm and peak areas were integrated automatically by computer using the Autochro-2000 software program. Separation was carried out at room temperature using a Varian, Microsorb-MV 100-5 C18 column (250 x 4.6 mm; North America). All the calculations concerning the quantitative analysis were performed with external standardization by the measurement of peak areas.

 

Stock and Standard Solutions:

Paracetamol (100.00 mg) was accurately weighed in a 100 ml volumetric flask and dissolved in the mobile phase and filled up to volume with the mobile phase.

 

Standard Working Solution:

Standard working solutions were prepared individually in mobile phase for paracetamol. Aliquots from working solution was combined and diluted with mobile phase to yield a solution with final concentrations of 5 μg/ml, 10 μg/ml and 15 μg/ml. Studies on the stability of the analytes in standard working solution showed that there were no decomposition products in the chromatogram or difference in areas during analytical procedure, even after storage for four days at 40C.

 

PROCEDURE:

Chromatographic Conditions:

HPLC analysis was performed by isocratic elution with a flow rate of 0.5 ml/min. The mobile phase composition was methanol-water (30:70) (v/v). All solvents were filtered through a 0.25 μm millipore filter before use and degassed in an ultrasonic bath. Volumes of 10 μl prepared solutions and samples were injected into the column using auto sampler. Quantification was effected by measuring at 245 nm as established from the three-dimensional chromatogram. The chromatographic run time was 10 min and the column void volume was 1.735 min. Throughout the study, the suitability of the chromatographic system was monitored by overlapping figures.

 

Figure 1: Chromatogram of 245nm and 0.5 Flow Rate at Room Temperature (5 μg/ml)

 

Figure 2: Chromatogram of 245nm and 0.5 Flow Rate at Room Temperature (10 μg/ml)

 

Calibration:

Standard solutions containing paracetamol between 5-15 μg/ml was prepared in the mobile phase. Triplicate 20 μl injections were made for each standard solution to see the reproducibility of the detector response at each concentration level. The peak area of each was plotted against the concentration to obtain the calibration graph. The three concentrations of each sample were subjected to regression analysis to calculate the calibration equation and correlation coefficients.

 

RESULTS AND DISCUSSION:

Method Development:

The mobile phase was chosen after several trials with methanol, isopropyl alcohol, acetonitrile, water and buffer solutions in various proportions and at different pH values. A mobile phase consisting of methanol-water (30:70) (v/v) was selected to achieve maximum sensitivity with minimum composition and quantity of organic mobile phase.

 

 

Table 1: Calibration Result (Figure 6)

Sr. No.

Name

Area

Height

Amount

Response factor

1.

5 μg/ml

680.250

50.375

5.000

0.007350

2.

10 μg/ml

1320.304

99.183

10.000

0.007574

3.

15 μg/ml

2002.388

137.858

15.000

0.007491

 

Table 2: Precision of the development method at LOQ level (n = 6)

Compound

λ

Peak  Area  (mean)

n = 6

Amount

SD %

Paracetamol (5 μg/ml)

245 nm

680.250

5.000

1.18

Paracetamol (10 μg/ml)

245 nm

1320.304

10.000

1.83

Paracetamol (15 μg/ml)

245 nm

2002.388

15.000

2.01

Paracetamol (100 μg/ml)

245 nm

9446.444

100.000

5.61

Unknown (about 25 μg/ml)

245 nm

3.27.488

23.468

2.36

 

Flow rates between 0.5 and 1.0 ml/min were studied. A flow rate of 0.5 ml/min gave an optimal signal to noise ratio with a reasonable separation time. Using a reversed-phase C18 column, the retention times for paracetamol was observed to be 8.1 min. Total time of analysis was less than 9 min. The maximum absorption of paracetamol detected at 245 nm and this wavelength was chosen for the analysis. The chromatogram at 245 nm showed a complete resolution of all peaks with selected composition of mobile phase (Figure 1, 2, 3 and 4)

Figure 1, 2, 3 and 4 Chromatogram of the paracetamol by the RP-HPLC method

 

Linearity:

Table 1 presents the equation of the regression line, correlation coefficient (r2), standard deviation (SD), values of coefficient of determinant for compound. Excellent linearity was obtained for compounds between the peak areas and concentrations of 5- 15 μg/ml with correlation coefficient r2  = 0.99980 for paracetamol.

Equation of regression line:

 

Amount=a*Area+b (Y=a*Area+b);   a: 0.00750 b: 0

 

Standard Deviation: 0.10039

Correlation Coefficient: 0.99980

Coefficient of Determinant: 0.99960

 

Figure 3: Chromatogram of 245nm and 0.5 Flow Rate at Room Temperature (15 μg/ml)

 

Figure 4: Chromatogram of 245nm and 0.5 Flow Rate at Room Temperature (Unknown sample of the drug paracetamol)

 

Figure 5: Overlap graph of 5, 10, 15 μg/ml drug samples at 245nm and 0.5 Flow Rate at Room Temperature

 

Figure 6: Calibration report of 5, 10, 15 μg/ml drug samples at 245nm and 0.5 Flow Rate at Room Temperature

 

Limits of Detection and Quantification:

Limits of detection (LOD) were established at a signal-to-noise ratio (S/N) of 3. Limits of quanti cation (LOQ) were established at a signal-to-noise ratio (S/N) of 6. LOD and LOQ were experimentally veried by four injections of paracetamol at the LOD and LOQ concentrations. The LOD was calculated to be 0.816 μg/ml and the LOQ was calculated to be 1.226 μg/ml for paracetamol.

 

Suitability of the Method:

The chromatographic parameters such as resolution, selectivity and peak asymmetry were satisfactory for compounds (Figure 5) overlap 5, 10, 15

 

Table 3: Accuracy of the Developed Method (n= 6)

Compound

Spiked concentration (μg/ml)

Measured concentration (μg/ml)

SD %

% deviation

Paracetamol (100 μg/ml)

100

107.862

5.61

7.862

Unknown (about 25 μg/ml)

25

23.468

2.36

6.128

 

Precision:

The precision of the method (within-day variations of replicate determinations) was checked by injecting paracetamol 6 times at the LOQ level. The precision of the method, expressed as the SD % at the LOQ level was for each samples of paracetamol showed in Table 2.

 

Accuracy:

A standard working solution containing paracetamol drug concentrations of 100 μg/ml and 25 μg/ml respectively was prepared. The prepared sample of standards was injected 6 times as a test sample. From the respective area counts, the concentrations of the each paracetamol samples calculated using the detector responses. The accuracy, defined in terms of % deviation of the calculated concentrations from the actual concentrations, is listed in Table 3.

% Deviation = (Spiked Concentration - Mean Measured Concentration) / Spiked concentration X 100


CONCLUSION:

The developed method is suitable for the identification and quantification of the paracetamol with effective, less quantity and good combination of mobile phase. A high percentage of recovery shows that the method can be successfully used on a routine basis. The proposed method is simple, sensitive, rapid, specific and could be applied for quality and stability monitoring of paracetamol with such combination of mobile phase.

 

REFERENCES:

1.       Reynolds J.E.F. Martindale. The Extra Pharmacopoeia, Pharmaceutical Press, London, 1996.

2.       The United States Pharmacopoeia, U.S. Pharmacopeial Convention, Rockville, MD, 2000.

3.       British Pharmacopoeia CD, The Stationery O ce Ltd., Norwich, 1998.

4.       European Pharmacopoeia,Convention on the Elaboration of a European Parmacopoeia (European Treaty Series No. 50), Strasbourg, 1996.

5.       Lau OV, Luk SF and Cheung YM. Analyst. 1989; 114: 047-1051.

6.       El-Obeid HA and Al-Badr AA. Analytical Profiles of Drug Substances, Amer Pharma Assoc. 1985; 14: 551-596.

7.       Prodan E, Gere-Paszti O and Farkas E. Validation and Simultaneous Determination of Paracetamol and Caffeine in Pharmaceutical Formulations by RP-HPLC. Chem. Anal. 2003; 78:901-905.

8.       Pawar UD, Naik AV, Sulebhavikar AV and Mangaonkar KV. Simultaneous Determination of Aceclofenac, Paracetamol and Chlorzoxazone by HPLC in Tablet Dose Form. E-Journal of Chemistry. 2009; 6:289-294


 

 

 

Received on 25.02.2009       Modified on 23.04.2009

Accepted on 21.05.2009      © RJPT All right reserved

Research J. Pharm. and Tech.2 (4): Oct.-Dec. 2009; Page701-704